22
PROPERTIES Allow user to leave interaction: Anytime Show ‘Next Slide’ Button: Show always Completion Button Label: View Presentation Sepsis and Septic Shock Old Concepts, New Precepts Babak Sarani, MD Division of Traumatology and Surgical Critical Care, Department of Surgery University of Pennsylvania Slide 3 Systemic Inflammatory Response Syndrome (SIRS) Systemic inflammatory response to a variety of severe clinical insults. Manifested by two or more of the following: Temperature >38ºC or <36ºC Heart rate >90 beats/min Respiratory rate >20 breaths/min or PaCO2 <32 mm Hg WBC >12,000/mm3, <4000/mm3, or >10% immature (band) forms ACCP/SCCM Consensus Statement. Chest. 1992;101:1644-1655.

Adult ICU Sepsis

Embed Size (px)

DESCRIPTION

Sepsis Management in Adult ICU

Citation preview

  • PROPERTIESAllow user to leave interaction: AnytimeShow Next Slide Button: Show alwaysCompletion Button Label: View Presentation

    Sepsis and Septic ShockOld Concepts, New Precepts

    Babak Sarani, MDDivision of Traumatology and Surgical Critical

    Care, Department of Surgery

    University of Pennsylvania

    Slide 3

    Systemic Inflammatory Response Syndrome (SIRS)

    Systemic inflammatory response to a variety of severe clinical insults. Manifested by two or more of the following:

    Temperature >38C or 90 beats/min

    Respiratory rate >20 breaths/min or PaCO2 12,000/mm3, 10% immature (band) forms

    ACCP/SCCM Consensus Statement. Chest. 1992;101:1644-1655.

  • Slide 4

    Sepsis: ACCP/SCCM Definitions Sepsis

    Systemic response to infection i.e., confirmed or suspected infection plus 2 SIRS criteria

    Severe Sepsis

    Sepsis associated with organ dysfunction, hypoperfusion, or hypotension

    Septic Shock

    Severe Sepsis that cannot be resuscitated or stabilized with IV fluids aloneACCP/SCCM Consensus Statement. Chest. 1992;101:1644.

    Slide 5

    Sepsis - ACCP/SCCM Definitions: The Update

    Altered mental status

    Edema or increased fluid balance

    Hyperglycemia (absent diabetes)

    Increased CRP or procalcitonin

    Hypotension

    Increased SvO2

    CI >3.5 L/min/m2

    Arterial hypoxemia (PaO2/FiO2 2 hours)

    Increased serum Cr (>0.5 mg/dL)

    Coagulopathy (INR >1.5)

    Ileus (absent bowel sounds)

    Thrombocytopenia (40 mg/dLor 70 mmol/L)

    Hyperlactatemia (>1 mmol/L)

    Decreased capillary refill or mottling

    Levy MM et al. Crit Care Med. 2003.

    Slide 6

    Septic Shock : ACCP/SCCM Definition

    Sepsis-induced hypotension (despite adequate fluid resuscitation with the presence of perfusion abnormalities) may include, but are not limited to:

    lactic acidosis

    oliguria

    acute alteration of mental status

    Patients receiving inotropic or vasopressor agents may not be hypotensive at the time that perfusion abnormalities are measured.

    ACCP/SCCM Consensus Statement. Chest. 1992;101:1644-55.

  • Slide 7

    Martin GS et al. NEJM 2003;348:1346

    Population Adjusted Incidence of Sepsis (USA)

    Slide 8

    Comparative Incidence and Mortality

    Angus DC et al. Crit Care Med. 2001; 29:1303

    0

    50

    100

    150

    200

    250

    300

    AIDS Breast CA Prostate CA 1st MI Sepsis

    Incidence

    Cas

    esX1

    ,000

    0

    50000

    100000

    150000

    200000

    250000

    AIDS BreastCA

    ProstateCA

    AMI Sepss

    Mortality

    Dea

    ths\

    year

    Slide 9

    Martin GS et al. NEJM 2003;348:1346

    Hospital Mortality Rate of Patients with Sepsis in the USA

  • Slide 10

    Martin GS et al. NEJM 2003;348:1346

    Cases of Sepsis by Pathogen (USA)

    Slide 11

    Infection Source in Severe Sepsis

    44.0%

    17.3%9.1%

    8.6%

    6.6%

    2.2%

    8.0%

    6.0%

    10.8%RespiratoryBacteremiaGUAbdomenSoft tissueDeviceCNSEndocarditisOther

    Angus DC et al. Crit Care Med. 2001; 29:1303

    Slide 12Martin GS et al. NEJM 2003;348:1346

    Characteristics of Patients with Sepsis

  • Slide 13

    Organ Failure and Associated Mortality with Severe Sepsis

    Organ Failure Occurrence, % Mortality, %

    One 73.6 21.2

    Two 20.7 44.3

    Three 4.7 64.5

    Four 1.0 76.2

    Respiratory 45.8 40.1

    Cardiovascular 24.4 32.4

    Renal 22.0 38.2

    Hematologic 20.6 22.8

    Central nervous system 9.3 24.4

    Hepatic 1.3 54.3

    Angus DC et al. Crit Care Med. 2001; 29:1303

    Slide 14

    Determinants of Mortality Source control is most vital factor

    Resuscitation/re-establish perfusion in 6 hrs

    Appropriate antibiotic therapy within 1 hr of hypotension

    Slide 15

    ACCP/SCCM Consensus Statement. Chest. 1992;101:1644-55.

    Relationship of SIRS, Sepsis, and Infection

  • Slide 16

    Van der Poll T, van Deventer SJH. Infect Dis Clin North Am.

    Dynamic Nature of Sepsis

    Slide 17

    Hemodynamic Effects of Putative Septic Shock Mediators

    Putative

    Mediator

    Arterial

    Pressure

    Cardiac

    Output

    Systemic

    Vascular

    Resistance

    Ejection

    Fraction

    Miscellaneous

    Effects

    Endotoxin Decreased

    (human, canine)

    Increased

    (human, canine)

    Decreased

    (human, canine)

    Decreased

    (human, canine)

    WBC, pyrexia TNF, IL-1, IL-6

    TNF Decreased(human, canine)

    Increased

    (human, canine)

    Decreased

    (human, canine)

    Decreased

    (canine)

    Lactic acidosis,

    pulmonary edema,

    WBC, pyrexiaDIC, platelets

    IL-1 Decreased(human, canine)

    Increased

    (human, canine)

    Decreased

    (human, canine)

    Decreased

    (canine)

    Pyrexia,

    platelets

    IL-6No change

    (canine)

    No change

    (canine)

    No change

    (canine)?

    Hepatic acute phase

    response

    Kumar et al. J Cardiothorac Vasc Anesth. 2001.

    Slide 18

    Pathophysiology Distributive shock state

    Vasodilation of arterioles low SVR, low BP nitric oxide (endothelium is the culprit!)

    Compensate with tachycardia and elevated CO/CI

    Pre-capillary A-V shunts Low BP bypass capillary resistance beds

    Elevated SVO2 Elevated lactate

  • Slide 19

    Metabolic Derangements in Sepsis

    Elevated Lactate and MVO2:

    Micro-anatomic shunts (non-nutrient capillaries)

    Functional shunts (impaired microcirculatory vasomotor control)

    Citric acid (Krebs) cycle defect with anaerobic glycolysis

    Aerobic glycolysis with lactate production

    Slide 20

    Vasculature- Vasodilation- Vasoconstriction- Leukocyte Aggregation- Endothelial Cell Dysfunction

    Cellular Dysfunction

    Organs- Dysfunction- Metabolic Abnormalities

    Myocardium- Depression- Dilatation

    Shock

    Refractory HypotensionMultiple Organ DysfunctionRecovery

    Death

    Nucleus

    LysosomeMitochondria Actin/Myosin

    Membranechannel

    Membranereceptor

    Pathogenesis of Septic Shock

    Slide 21Waage A, Halstensen A, Espevick T. Lancet. 1987.

    Serum Concentrations in Survivors and Nonsurvivorsof Septic Shock

    150,000

    TNF

    units

    /mL

    seru

    m

    10

    400600

    1,0001,200

    Serum from patientswho died

    Serum from patientswho survived

    Detection limitfor TNF

    100,0001,400

    1,000

    200

    Tumor Necrosis Factor (TNF)

  • Slide 22

    Pathogen

    Inflammation Coagulation

    Monocyte

    Tissue FactorCytokines

    Pathophysiology of Sepsis

    Slide 23

    Coagulation CascadeSteps in

    coagulationCoagulation

    cascade

    Initiation TF/VIIa

    Propagation VIIIa

    Thrombin activity

    Fibrinogen Fibrin

    IXa

    IXX

    Xa

    IIVa

    IIa

    II indicates prothrombin; IIa, thrombin;IX, factor IX; IXa, activated factor IX; TF, tissue factor; Va, activated factor V; VIIa, activated factor VII; VIIIa, activated factor VIII; X, factor X; Xa, activated factor X.

    Weitz JI et al. Chest. 2001.

    Slide 24

    Coagulation in Sepsis

    Bernard GR et al. N Engl J Med. 2001;344:699-709.

    Inflammatory Responseto Infection

    Thrombotic Responseto Infection

    Fibrinolytic Responseto Infection

    Endothelium

    TAFI

    PAI-1

    Suppressedfibrinolysis

    Neutrophil

    Monocyte

    IL-6IL-1TNF

    Bacterial, viral, fungal or parasitic infection/endotoxin

    Bacterial, viral, fungal or parasitic infection/endotoxin

    IL-6

    Tissue Factor

    Tissue Factor

    COAGULATION CASCADE

    Factor Va

    Factor VIIIa

    THROMBIN

    FibrinFibrin clot

  • Slide 25

    Pathogenesis of Sepsis

    Slide 26

    Protein C Levels Decrease Before Diagnosis of Severe Sepsis

    Mesters et al. Crit Care Med. 2000;28:2209-2216.

    PC HEM

    20

    40

    60

    80

    100

    120

    WBCFever

    6 hr12 hr

    18 hr24 hr

    36 hr48 hr

    60 hr72 hr

    PC A

    ntig

    en (%

    )

    Severe Sepsis Patients

    Septic Shock Patients

    Average Time to Diagnose Severe Sepsis

    Slide 27

    Septic Shock The Spiral

  • Slide 28

    Sepsis: Hemostatic Imbalance

    Slide 29

    GTP cGMP

    BloodBlood EndotheliumEndothelium SmoothMuscle

    SmoothMuscle

    GTPGTP

    cGMPcGMP

    GC

    L-ArgL-ArgO2O2

    L-citrullineL-citrulline

    GCGCNONO..

    cNOSPlateletsPlatelets

    Nitric Oxide in the Vasculature

    Slide 30

    GTP cGMP

    BloodBlood EndotheliumEndothelium SmoothMuscle

    SmoothMuscle

    GTPGTP

    cGMPcGMP

    GC

    L-ArgL-ArgO2O2

    L-citrullineL-citrullineGCGC

    NONO

    iNOSPlateletsPlatelets

    iNOS

    cNOS

    EndotoxinCytokinesEndotoxinCytokines

    NONO

    Nitric Oxide in Sepsis

  • Slide 31

    Septic Shock Hemodynamics Warm (hyperdynamic) shock

    hypotensive

    tachycardia

    tachypnea

    bounding pulse

    warm, well-perfusedextremities

    skin flushed, moist

    Cold (hypodynamic) shock

    hypotensive

    tachycardia

    tachypnea

    narrow, thready pulse

    cold, poorly perfusedextremities

    skin pale, dry

    Slide 32

    Dilemmas in Diagnosing the Septic Patient

    Combine clinical exam and labs/imaging

    Physical exam alone is NOT adequate

    Elderly Cant mount a fever or leukocytosis

    Ability to develop bandemia preserved

    Immunosuppressed/steroids

    Slide 33

    Diagnosing Sepsis Lab tests: CBC, Chemistry, Cultures, lactate, SVO2

    SVO2 is a measure of O2 extraction (NL 70%) UNDER-RESUSCITATED septic pts have a LOW SVO2 RESUSCITATED septic pts have a HIGH SVO2

    Lactate is a measure of the severity of sepsis Lactate > 4 that does not correct in 6 hrs correlates with

    mortality

  • Slide 34

    Hemodynamics in sepsis Lactate

    Weil & Afifi, Circulation 1970.

    Slide 35

    Septic Shock Hemodynamics CVP does not accurately estimate ventricular filling

    pressures in the critically ill.

    When PCWP (PAOP) is appropriately elevated with resuscitation, 90% of patients with septic shock exhibit a hyperdynamic circulatory state.

    Hyperdynamic state persists to death.

    Slide 36

    Car

    diac

    Inde

    x (L

    /min

    /m2)

    Time (days)

    Parker et al. Ann Intern Med. 1984

    1

    0

    2

    5

    6

    3

    4

    1 2 4 7 10 1 2 4 7 10

    7

    SurvivorsNonsurvivorsAll Patients

    Cardiac Index in Septic Shock (post-1980)

  • Slide 37

    Hypovolemia in Septic Shock Causes:

    Venous pooling

    Interstitial third-spacing

    w Insensible losses (fever, RR) w Oral intake

    Slide 38

    Septic Shock Hemodynamics Hypodynamic septic shock in humans = inadequately

    fluid-resuscitated septic shock

    Slide 39Mizock BA. Crit Care Med. 1992;20:80-93.

    Oxy

    gen

    Con

    sum

    ptio

    n

    Oxygen Delivery

    Critical DeliveryThreshold

    Lacti

    c Acid

    osis

    Physiologic Oxygen SupplyPhysiologic oxygen supply dependency indicating a critical delivery threshold below which lactic acidosis ensues

  • Slide 40

    Mizock BA. Crit Care Med. 1992;20:80-93.

    Oxy

    gen

    Con

    sum

    ptio

    n

    Oxygen Delivery

    Pathologic

    Physiologic

    Oxygen Delivery and Consumption

    The relationship between oxygen delivery and consumption under physiologic and pathologic conditions is demonstrated on this chart.

    Slide 41

    Capillary

    Vascular Abnormality

    Arteriole

    NeutrophilAggregation

    VasoconstrictionVasodilation

    Endothelial CellDestruction

    Venule

    Cell

    Pathogenesis of Septic Shock

    Slide 42

    Treatment of Septic Shock Source Control When Possible

    Based on Early Goal Directed Therapy

    Broad, high dose, rapid administration of antibiotics

    Consider Activated Protein C

    Minimal role for steroidsSurviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, 2008. Critical Care Med

  • Slide 43

    16% absolute reduction in mortality

    Rivers, NEJM 2001; 345:1368

    Cultures

    Slide 44

    Treatment - Fluids Endpoints of therapy

    MAP > 65 mm Hg, HR < 100 bpm

    UOP > 0.5 cc/kg/hr

    SVO2 70% or more

    CVP > 10-15 mm Hg Higher if known cardiomegaly or intubated

    TTE showing cardiac filling

    Until you no longer see improvement in hemodynamics following boluses

    Slide 45

    Failure to Intervene

    Sebat CCM 2007; 35: 2568

  • Slide 46

    Treatment - Steroids Recommended only for shock refractory to pressors *Multicenter, European, RCT

    Pts with vasopressor-resistant hypotension Improved mortality if rise in cortisol following ACTH was < 9mcg/dL

    and if baseline cortisol < 21 mcg/dL **CORTICUS larger, European, RCT

    All pts with septic shock (regardless of vasopressor response) No difference in mortality but vasopressor sparing effect with

    steroids ACTH stimulation could not predict who had endogenous cortisol

    deficiency

    *JAMA 2002; 288:862

    **NEJM 2008; 358:111

    Slide 47

    Hemodynamics in sepsisDeterminants of oxygen delivery (DO2)

    DO2

    Cardiac output

    Oxygen content

    Heart rateStroke volume

    Hemoglobin

    PaO2

    O2 Sat %

    Slide 48

    Failure to Intervene

    Sebat CCM 35: 2568; 2007

  • Slide 49

    Treatment

    Slide 50

    Treatment - Drotrecogin Alfa Protein C levels decrease before the onset of signs of

    septic shock and are associated with worsened mortality

    Activated protein C

    Anticoagulant (inhibits Factors V and VIII) Stop microthrombi formation and prevent end-organ loss?

    Endothelial cell stabilizer (anti-inflammatory) Stop excessive production of cytokines and apoptosis?

    Slide 51

    Treatment - Drotrecogin Alfa PROWESS RCT, 1690 pts, stopped early

    532 surgical pts

    6% decrease in mortality overall Greatest decrease if APACHE II score > 25

    1.5% increase in risk of bleeding Equal between medical and surgical groups

    Bernard. NEJM 2001; 344:699

  • Case StudyThe following are case studies that can be used for review of this presentation.

    Review Cases

    Skip

    Slide 53

    Patient Presentation 45 year old male, fall down steps

    No LOC

    Arrives with c/o severe left hip/buttock pain

    Slide 54

    History PMH: None

    PSH: None

    Med: None

    Allergy: None

    Social: Occasional EtOH only

    Travel: None

  • Slide 55

    PE P 105 BP 110/55 RR 20 T 99.7

    A&O with left hip/buttock pain, GCS = 15

    Salient Findings:

    Pelvis stable, intact grossly

    Left buttock tensely swollen

    LLE neurovascularly intact, no deformity

    Perineal / Rectal exam normal

    Slide 56

    X-rays

    Slide 57

    X-rays

  • Slide 58

    Scan

    Slide 59

    Labs WBC 19

    Hg 11

    Plt 171

    Na 136; Cl 104; HCO3 12; BUN 42, Cr 4.2

    Lactate 5.4 to 6.4

    SVO2 39%

    Slide 60

    Hospital Course Pt talking on phone to wife regarding need for operation

  • Slide 61

    Hospital Course Resuscitate, antibiotics

    Co-oximeter catheter inserted, vasopressors

    Endpoints: UOP, BP, CVP, lactate, SVO2 OR for serial debridements

    Discharged to home with VAC dressings

    Conclusion Tenets of Septic Shock and its Resuscitation

    Source control is imperative

    Broad spectrum, high dose, emperic antibiotics pending culture results

    Resuscitate to established endpoints of perfusion and avoid excess fluid administration

    Mixed venous oxygen saturation

    Biochemical markers (lactate)

    Echocardiogram to establish ideal CVP or L atrial pressure

    Urine output

    Mental StatusSlide 62

    Self AssessmentReady to test your knowledge?

    Take the Review

    Skip the Review

  • PROPERTIESOn passing, 'Finish' button: Goes to Next SlideOn failing, 'Finish' button: Goes to Next SlideAllow user to leave quiz: At any timeUser may view slides after quiz: At any timeUser may attempt quiz: Unlimited times

    Slide 65

    References Martin GS, Mannino GM, Eaton S, et al. NEJM 2003;348:1546-54.

    Angus DC, Linde-Zwirble WT, Lidicker J, et al. Crit Care Med 2001;29:1303-1310.

    Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet. 2005;365:63-78.

    Aird WC. Vascular bed-specific hemostasis: role of endothelium in sepsis pathogenesis. Crit Care Med. 2001;29:S28-S34.

    Kumar A, Haery C, Parrillo JE. Myocardial dysfunction in septic shock. Crit Care Clin. 2000;16:251-287.

    Levy MM, Fink MP, Marsahll JC, et al. Crit Care Med 2003;31:1250-1256